These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22729944)

  • 1. The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites.
    Pineda MA; McGrath MA; Smith PC; Al-Riyami L; Rzepecka J; Gracie JA; Harnett W; Harnett MM
    Arthritis Rheum; 2012 Oct; 64(10):3168-78. PubMed ID: 22729944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints.
    Rodgers DT; Pineda MA; McGrath MA; Al-Riyami L; Harnett W; Harnett MM
    Immunology; 2014 Mar; 141(3):457-66. PubMed ID: 24708419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints.
    Pineda MA; Rodgers DT; Al-Riyami L; Harnett W; Harnett MM
    Arthritis Rheumatol; 2014 Jun; 66(6):1492-503. PubMed ID: 24497523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis.
    Ju JH; Cho ML; Jhun JY; Park MJ; Oh HJ; Min SY; Cho YG; Hwang SY; Kwok SK; Seo SH; Yoon CH; Park SH; Kim HY
    Immunol Lett; 2008 Apr; 117(1):16-25. PubMed ID: 18242716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
    Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
    Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
    Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of T-bet gene regulates murine autoimmune arthritis.
    Kondo Y; Iizuka M; Wakamatsu E; Yao Z; Tahara M; Tsuboi H; Sugihara M; Hayashi T; Yoh K; Takahashi S; Matsumoto I; Sumida T
    Arthritis Rheum; 2012 Jan; 64(1):162-72. PubMed ID: 21905017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
    Hartgring SA; Willis CR; Alcorn D; Nelson LJ; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Sep; 62(9):2716-25. PubMed ID: 20499386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin octapeptide significantly suppresses collagen-induced arthritis in mice by inhibiting Th17 polarization primed by dendritic cells.
    Li Q; Han D; Cong B; Shan B; Zhang J; Chen H; Ma C; Liyanage SS
    Cell Immunol; 2011; 272(1):53-60. PubMed ID: 22004797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
    Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
    Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation.
    Wen T; Li Y; Wu M; Sun X; Bao X; Lin Y; Hao J; Han L; Cao G; Wang Z; Liu Y; Wu Z; Hong Z; Wang P; Zhao L; Li Z; Wang Q; Yin Z
    Arthritis Rheum; 2012 Sep; 64(9):2896-906. PubMed ID: 22576707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.